daydreamer11 wrote:Does anyone know the efficacy rate of Tysabri? I tried to find it on pubmed, but I don't really know where to look in the endless reports.
Harry, not speaking to Tysabri explicitly, I have heard this statement many times (probably yourself)_ I am a bit lazy, but have they found that generally speaking, playing the "odds", the greater the number of lesions, the greater the disability? Or is it completely random when plotted on a graph? Is it at all common for people to increase in lesion load while reducing in disability? or vice versa?HarryZ wrote:They also said that the number of brain lesions was reduced significantly although lesions are known to come and go without medications and they do not correlate with MS symptoms.
CureOrBust wrote:Harry, not speaking to Tysabri explicitly, I have heard this statement many times (probably yourself)_ I am a bit lazy, but have they found that generally speaking, playing the "odds", the greater the number of lesions, the greater the disability? Or is it completely random when plotted on a graph? Is it at all common for people to increase in lesion load while reducing in disability? or vice versa?HarryZ wrote:They also said that the number of brain lesions was reduced significantly although lesions are known to come and go without medications and they do not correlate with MS symptoms.
CureOrBust wrote:even if lesions and symptoms may come and go on the individual, I think they would rely on the statistical outcomes.
Return to Tysabri (Antegren or Natalizumab)
Users browsing this forum: No registered users